Learn About Sex-Related Health Issues. Get the facts on sexually transmitted diseases, prostate issues, pregnancy, impotence, menopause, birth control and much more.
A Member of the Healthscout Network
 Printer Friendly  Send to a Friend

New Study Finds HPV Vaccine Protects Against Genital Warts

Industry-funded research also finds the shot helps protect against precancerous growths

TUESDAY, July 20 (HealthDay News) -- A new study finds that the human papillomavirus (HPV) vaccine protects not only against the sexually transmitted virus that causes cervical cancer, but also helps prevent genital warts and low-grade cervical growths.

The findings are published in the July 21 online edition of BMJ. Health officials in the United States have been urging vaccination of young women and girls.

Advertisement
Related Stories
 border=
Facebook Might Be Tough on Users With Low Self-Esteem
Fewer U.S. Teens Having Babies, Binge Drinking: Report
Satisfaction With Life Seems Good for the Heart
Related Videos
 border=
Baby Steps: Fertility Findings
Don't Wait on Your Prostate
Risky Wrap: The Dangers of Swaddling
Related Slides
 border=
Penile Implants
Placenta Abruptio
PMS
Related Encyclopedia
 border=
AIDS and HIV Infection
Bashful Bladder Syndrome
Birth Control


The researchers estimate that the virus causes an estimated 500,000 cases of cervical cancer in women each year around the world. The virus can also cause warts in the genital area and low-grade cervical growths. Those two conditions are thought to strike 30 million people annually.

In the just-released randomized control trial, researchers studied 17,622 women in 24 countries and territories who had been assigned to take the vaccine or a placebo over a six-month period. The women were aged 16 to 26.

Joakim Dillner, of the department of medical microbiology, Lund University, Malmo University in Sweden, and colleagues found that the vaccine provided significant protection against the warts and tumors in susceptible women. For example, 168 of 7,632 women who took the placebo developed cervical growths attributed to HPV strains, while just seven of the 7,629 who took the vaccine did, they noted.

In the big picture, the study authors wrote, the vaccine "provided strong and sustained protection" for four years against various types of warts and low-grade female genital growths.

The study was funded by Merck Research Laboratories, a division of Merck & Company, maker of the HPV vaccine Gardasil.

Dr. Clyde Crumpacker, a professor of medicine at Harvard Medical School in Boston, said in an interview that the study is useful because it shows the vaccine can do more than prevent the virus from spreading.

"The vaccine has not yet been licensed for boys, but this study provides a strong case that boys should be vaccinated to prevent acquisition of HPV and prevent genital warts," said Crumpacker.

More information

The U.S. National Library of Medicine has more on HPV.

-- Randy Dotinga

SOURCES: BMJ, news release, July 20, 2010; Clyde Crumpacker, M.D., professor, medicine, Harvard Medical School, Boston

Copyright © 2010 HealthDay. All rights reserved.
Last updated 7/20/2010



Disclaimer: The information provided on this website is for educational purposes only and does not serve as a replacement for care provided by your own personal health care team. This website does not render or provide medical advice, and no individual should make any medical decisions or change their health behavior based on information provided here. All pertinent content provided on this website should be discussed with your personal physician to evaluate whether it has any relevance to or impact on your specific condition. Reliance on any information provided by this website is solely at your own risk.


Feb 9, 2012
Home
Search
Powered By HealthLine
New! For timely and trustworth health information, expert advice and much more, visit Erectile Facts
Patient Guide
News
Health Videos
Health Encyclopedia
Health News Archive
Affiliate Information
HealthScout Network
Contact Us
Newsletters
Privacy Policy
Terms of Use

We comply with the HONcode standard for trustworthy health
information:
verify here.
About The HealthScout Network Contact Us
Copyright © 2001. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service  

To find more information on specific conditions, please visit our partner sites: